As developments in AI and personalisation continue to gather momentum, medtech innovation is attracting increased interest from investors. The team at McDermott Will & Emery draw on the debate from the firm’s 2024 Healthcare Private Equity Europe conference to assess the current landscape and the outlook The escalating pace of innovation in medtech continues to…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
